PL374420A1 - Proces wytwarzania kompozytu z kopolimeru blokowego i leku - Google Patents

Proces wytwarzania kompozytu z kopolimeru blokowego i leku

Info

Publication number
PL374420A1
PL374420A1 PL03374420A PL37442003A PL374420A1 PL 374420 A1 PL374420 A1 PL 374420A1 PL 03374420 A PL03374420 A PL 03374420A PL 37442003 A PL37442003 A PL 37442003A PL 374420 A1 PL374420 A1 PL 374420A1
Authority
PL
Poland
Prior art keywords
drug
making
block copolymer
copolymer composite
composite
Prior art date
Application number
PL03374420A
Other languages
English (en)
Inventor
Takeshi Nakanishi
Kazuhisa Shimizu
Original Assignee
Nippon Kayaku Kabushiki Kaisha
Japan Science And Technology Agency
Sakurai Yasuhisa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nippon Kayaku Kabushiki Kaisha, Japan Science And Technology Agency, Sakurai Yasuhisa filed Critical Nippon Kayaku Kabushiki Kaisha
Publication of PL374420A1 publication Critical patent/PL374420A1/pl

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/74Synthetic polymeric materials
    • A61K31/785Polymers containing nitrogen
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A61K31/704Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6905Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a colloid or an emulsion
    • A61K47/6907Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a colloid or an emulsion the form being a microemulsion, nanoemulsion or micelle
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08GMACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G73/00Macromolecular compounds obtained by reactions forming a linkage containing nitrogen with or without oxygen or carbon in the main chain of the macromolecule, not provided for in groups C08G12/00 - C08G71/00
    • C08G73/06Polycondensates having nitrogen-containing heterocyclic rings in the main chain of the macromolecule
    • C08G73/10Polyimides; Polyester-imides; Polyamide-imides; Polyamide acids or similar polyimide precursors
    • C08G73/1092Polysuccinimides
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08LCOMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L71/00Compositions of polyethers obtained by reactions forming an ether link in the main chain; Compositions of derivatives of such polymers
    • C08L71/08Polyethers derived from hydroxy compounds or from their metallic derivatives
    • C08L71/10Polyethers derived from hydroxy compounds or from their metallic derivatives from phenols

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Polymers & Plastics (AREA)
  • Inorganic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nanotechnology (AREA)
  • Dispersion Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Processes Of Treating Macromolecular Substances (AREA)
PL03374420A 2002-06-19 2003-06-18 Proces wytwarzania kompozytu z kopolimeru blokowego i leku PL374420A1 (pl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2002178619A JP2004018494A (ja) 2002-06-19 2002-06-19 ブロック共重合体−薬剤複合体の製造法

Publications (1)

Publication Number Publication Date
PL374420A1 true PL374420A1 (pl) 2005-10-17

Family

ID=29996532

Family Applications (1)

Application Number Title Priority Date Filing Date
PL03374420A PL374420A1 (pl) 2002-06-19 2003-06-18 Proces wytwarzania kompozytu z kopolimeru blokowego i leku

Country Status (10)

Country Link
US (1) US20050214375A1 (pl)
EP (1) EP1514560A4 (pl)
JP (1) JP2004018494A (pl)
KR (1) KR20050013575A (pl)
CN (1) CN1662259A (pl)
AU (1) AU2003242463B2 (pl)
CA (1) CA2490704A1 (pl)
PL (1) PL374420A1 (pl)
RU (1) RU2316314C2 (pl)
WO (1) WO2004000362A1 (pl)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004035013A2 (en) * 2002-10-21 2004-04-29 L'oreal Process for dissolving lipophilic compounds, and cosmetic composition
US7601796B2 (en) * 2005-01-04 2009-10-13 Intezyne Technologies, Inc. Synthesis of hybrid block copolymers and uses thereof
US20110124840A1 (en) * 2005-02-11 2011-05-26 Kurt Breitenkamp Synthesis of Homopolymers and Block Copolymers
MX2007012157A (es) 2005-04-01 2008-03-14 Intezyne Technologies Llc Micelas polimericas para suministro de farmacos.
CA2631704A1 (en) 2005-12-05 2007-06-14 Nitto Denko Corporation Polyglutamate-amino acid conjugates and methods
WO2007136134A1 (ja) * 2006-05-23 2007-11-29 Nanocarrier Co., Ltd. 疎水性薬物内包ポリマーミセルの製造方法
AU2007311980B2 (en) * 2006-10-19 2012-05-31 Nano Mrna Co., Ltd. Block copolymer for drug complex and pharmaceutical composition
US20080181852A1 (en) * 2007-01-29 2008-07-31 Nitto Denko Corporation Multi-functional Drug Carriers
JP2010528122A (ja) * 2007-05-09 2010-08-19 日東電工株式会社 白金薬剤と結合されたポリマー
CA2683590A1 (en) * 2007-05-09 2008-11-20 Nitto Denko Corporation Compositions that include a hydrophobic compound and a polyamino acid conjugate
CN101707869A (zh) * 2007-05-09 2010-05-12 日东电工株式会社 具有多种药物的聚谷氨酸盐结合物和聚谷氨酸盐-氨基酸结合物
JP5349318B2 (ja) * 2007-09-28 2013-11-20 日本化薬株式会社 ステロイド類の高分子結合体
EP2201935B1 (en) * 2008-12-26 2020-07-08 Samyang Biopharmaceuticals Corporation Polymeric micelle composition containing a poorly soluble drug and preparation method of the same
CN104434877A (zh) * 2013-09-16 2015-03-25 成都市绿科华通科技有限公司 一种含聚甲基烯酸的高分子药物微胶囊
CN104434878A (zh) * 2013-09-16 2015-03-25 成都市绿科华通科技有限公司 含聚甲基丙烯酸的自组装药物载体微胶囊体系
EP2942348B1 (en) 2014-05-07 2017-10-25 Johannes Gutenberg-Universität Mainz Thiol-protected amino acid derivatives and uses thereof
CA3184476A1 (en) * 2020-06-02 2021-12-09 Purdue Research Foundation Formulation of monodisperse kinetically frozen polymer micelles via equilibration-nanoprecipitation

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4027013A (en) * 1976-01-22 1977-05-31 William L. Wilson Clottable fibrinogen free factor VIII and albumin product and process
JP2517760B2 (ja) * 1989-05-11 1996-07-24 新技術事業団 水溶性高分子化医薬製剤
JP3310000B2 (ja) * 1990-11-07 2002-07-29 靖久 桜井 水溶性高分子抗癌剤及び薬物担持用担体
KR940003548U (ko) * 1992-08-14 1994-02-21 김형술 세탁물 건조기
JP3682475B2 (ja) * 1993-08-31 2005-08-10 靖久 桜井 水溶性抗癌剤
DE69625326T2 (de) * 1995-09-29 2003-09-18 Japan Science And Technology Corp., Kawaguchi Anthracyclinderivate und sie enthaldende medizinische zubereitungen
US6916488B1 (en) * 1999-11-05 2005-07-12 Biocure, Inc. Amphiphilic polymeric vesicles

Also Published As

Publication number Publication date
AU2003242463A1 (en) 2004-01-06
JP2004018494A (ja) 2004-01-22
WO2004000362A1 (ja) 2003-12-31
RU2316314C2 (ru) 2008-02-10
RU2005101084A (ru) 2005-06-10
EP1514560A1 (en) 2005-03-16
CN1662259A (zh) 2005-08-31
CA2490704A1 (en) 2003-12-31
KR20050013575A (ko) 2005-02-04
US20050214375A1 (en) 2005-09-29
AU2003242463B2 (en) 2009-07-23
EP1514560A4 (en) 2008-07-02

Similar Documents

Publication Publication Date Title
PL374420A1 (pl) Proces wytwarzania kompozytu z kopolimeru blokowego i leku
PL378168A1 (pl) Dihydropterydynony, sposoby ich wytwarzania i ich zastosowanie w postaci leków
DE60225385D1 (de) Autentisches Document und dessen Herstellungsverfahren
DE60319810D1 (de) Anschwemmfiltermedien und herstellungs- und verwendungsverfahren
PL375691A1 (pl) Imidazolopirydyny i sposoby ich wytwarzania i stosowania
AU2003243470A1 (en) Flexible mold and method of manufacturing microstructure using the same
AU2003279819A1 (en) Shrimp and the production thereof
TWI348923B (en) Pharmaceutical composition of rapid disintegrating tablet and method of preparing the same
MA27366A1 (fr) Nouveaux derives de thiophenylglycoside, methodes pour leur production, medicaments contenant lesdits composes et leur utilisation
DE60310339D1 (de) Querträger und Herstellungsverfahren
AU2003293649A1 (en) Novel xanthine derivatives, the production and the use thereof in the form of drugs
ATE448295T1 (de) Künstliche dermis und herstellungsverfahren dafür
EP1624935A4 (en) ANTI-ADHESION COMPOUNDS AND USE METHOD THEREFOR
IS7699A (is) Afleiður af díoxan-2-alkýl karbamötum, framleiðslu aðferð þeirra og notkun við meðferð sjúkdóma
IS7564A (is) Lyfjablanda með breytta losun
ITTO20020741A1 (it) Turbo-ventola e stampo utilizzato per la sua fabbricazione.
AU2003291128A8 (en) Lens molds and method of using the same
SG116507A1 (en) Pharmaceutical dosage form and method of making.
AU2003255612A8 (en) Novel multimeric molecules, the preparation method thereof and use of same for the preparation of medicaments
DE60334632D1 (de) Mechanolumineszenzstoff und dessen herstellung
DE50214244D1 (de) Klauenpolläufer und dessen herstellverfahren
EP1568691A4 (en) ACCELERATOR FOR ERYTHROPOETIN PRODUCTION
PL361518A1 (pl) Zastosowanie substancji oraz kompozycja farmaceutyczna
DE69941825D1 (de) Arzneistoffhaltiger kaugummi, dessen herstellungsverfahren und so erhaltene tablette
AU2003304246A1 (en) Method of forming nanostructures on ceramics and the ceramics formed

Legal Events

Date Code Title Description
REFS Decisions on refusal to grant patents (taken after the publication of the particulars of the applications)